Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One ...

Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Medications designed to treat diabetes by lowering blood sugar levels, like Ozempic, continue to turn up added benefits, and ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...

Semaglutide (Ozempic) was approved for treating type 2 diabetes in 2017, but has since been used as a weight-loss drug. Now, an analysis of Alzheimer’s diagnoses in people who were prescribed ...

Originally developed to manage blood sugar in type 2 diabetes, drugs like semaglutide — sold under brand names Ozempic and Wegovy ... safer options beyond current Alzheimer’s drugs ...